More on amrn
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.06 |
|
|||
| Open | $14.04 | ||||
| 52 Wk High | $3.65 | ||||
| 52 Wk Low | $1.24 | ||||
| Day High | $14.23 | ||||
| Day Low | $14.02 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 36,564 | ||||
- JPMorgan Reinstates Amarin Corporation (AMRN) at Underweight
- Form 4 AMARIN CORP PLC\UK For: Aug 01 Filed by: Fishman Peter L.
- Amarin Corp. (AMRN) Reports In-Line Q2 EPS
- Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
- Form 4 AMARIN CORP PLC\UK For: Jul 01 Filed by: Ketchum Steven B
- Form 4 AMARIN CORP PLC\UK For: Jul 01 Filed by: Keenan David Paul
- Form 4 AMARIN CORP PLC\UK For: Jul 01 Filed by: Fishman Peter L.
- Form 4 AMARIN CORP PLC\UK For: Jul 01 Filed by: Provoost Jonathan
- Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
- Form 4 AMARIN CORP PLC\UK For: Jun 26 Filed by: Berg Aaron
Entities mentioned with amrn
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Jefferies & Co | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- AdCom | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Options | View Related Stories »
- Show More...
